These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6592940)

  • 1. Ticlopidine: quo vadis?
    Agents Actions Suppl; 1984; 15():1-312. PubMed ID: 6592940
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H; Mizukami M; Kitamura K; Kikuchi H
    Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of platelet aggregation in patients treated with ticlopidine].
    Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
    Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
    [No Abstract]   [Full Text] [Related]  

  • 4. Ticlopidine: quo vadis? Adverse reactions in man.
    Goyan JE
    Agents Actions Suppl; 1984; 15():116-25. PubMed ID: 6592942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ticlid].
    Drouet L
    Soins; 1985 May; (454):I-II. PubMed ID: 3848119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental study of the effect of ticlopidine chlorhydrate on the development of atherosclerotic lesions].
    Viver Manresa E; Huguet Redecilla P
    Angiologia; 1986; 38(3):134-49. PubMed ID: 3740536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ticlopidine in the prevention of recurrent cerebral ischemic accidents].
    Herce Muñoz M
    Med Clin (Barc); 1984 Oct; 83(12):517-8. PubMed ID: 6513628
    [No Abstract]   [Full Text] [Related]  

  • 8. Ticlopidine and coronary surgery.
    Limet R; David JL; Rigo P
    Agents Actions Suppl; 1984; 15():188-98. PubMed ID: 6385646
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant.
    Sablayrolles M; Wajcman H; Castaigne JP; Labie D
    Haematologia (Budap); 1984; 17(2):199-207. PubMed ID: 6534828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
    Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
    Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises.
    Cabannes R; Lonsdorfer J; Castaigne JP; Ondo A; Plassard A; Zohoun I
    Agents Actions Suppl; 1984; 15():199-212. PubMed ID: 6385647
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview: clinical experiences with ticlopidine.
    Day HJ
    Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis.
    Lonsdorfer J; Castaigne JP; Lenormand E; Otayeck A; Bogui P; Dosso Y; Cabannes R
    Agents Actions Suppl; 1984; 15():213-8. PubMed ID: 6592944
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
    Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
    Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results in peripheral arterial revascularization with the use of various antiaggregating substances].
    Garrido García H; Rivas Marín J; Vilaplana Serrano F; Martín Infante A
    Rev Clin Esp; 1984 May; 173(4):231-4. PubMed ID: 6207564
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
    de Gaetano G; Bertelé V
    Arq Bras Cardiol; 1983 Dec; 41(6):425-7. PubMed ID: 6678584
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview: pharmacology of ticlopidine.
    Gordon JL
    Agents Actions Suppl; 1984; 15():108-15. PubMed ID: 6385643
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.